Australasian Lung Cancer Trials Group

Home
Trials Print E-mail

ALTG Trials

The following ALTG trials are listed on the Australian and New Zealand Clinical Trials Registry website:

Trial Number  Title  ACTR Number 
ALTG 04/008 

ANTS Trial (Australian Neoadjuvant Therapy Study for Non-small Cell Lung Cancer). A randomised phase II study comparing cisplatin and docetaxel with or without cetuximab given as neoadjuvant therapy in patients with stage II and IIIA resectable non-small cell lung cancer.  

ACTRN12608000061336
ALTG 04/009 PACT: Patients’ perceptions of adjuvant chemotherapy (ACT) for early NSCLC: What makes it worthwhile?  PACT Flyer 
ALTG 06/003 NITRO: A Phase III, randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer   ACTRN12608000588392
ALTG 08/001 PA in Lung:The impact of physical activity on quality of life in patients with thoracic cancer  PA in Lung Flyer 
ALTG 09/001 BR.29. A double blind randomised trial of cediranib versus placebo in patients receiving paclitaxel/carboplatin chemotherapy for the treatment of advanced or metastatic non-small cell lung cancer. ACTRN12609000247279 
ALTG 09/002  BR.26. A Double Blind Placebo Controlled Randomised Trial of PF-804 in Patients with Incurable Stage IIIB / IV Non-small Cell Lung Cancer After Failure of Standard Therapy for Advanced or Metastatic Disease ACTRN12610000312044
ALTG 09/004  B2P2M2: Phase II, single arm trial to evaluate the response rate of BNC105P as 2nd line chemotherapy for advanced malignant pleural mesothelioma ACTRN12610000093088 
Last Updated ( Tuesday, 18 May 2010 )